You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API rifabutin


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing rifabutin

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Pfizer Laboratories Div Pfizer Inc MYCOBUTIN rifabutin 0013-5301 CELLULOSE, MICROCRYSTALLINE
Pfizer Laboratories Div Pfizer Inc MYCOBUTIN rifabutin 0013-5301 FERRIC OXIDE RED
Pfizer Laboratories Div Pfizer Inc MYCOBUTIN rifabutin 0013-5301 MAGNESIUM STEARATE
Pfizer Laboratories Div Pfizer Inc MYCOBUTIN rifabutin 0013-5301 SILICON DIOXIDE
Pfizer Laboratories Div Pfizer Inc MYCOBUTIN rifabutin 0013-5301 SODIUM LAURYL SULFATE
Pfizer Laboratories Div Pfizer Inc MYCOBUTIN rifabutin 0013-5301 TITANIUM DIOXIDE
Physicians Total Care Inc MYCOBUTIN rifabutin 54868-2841 CELLULOSE, MICROCRYSTALLINE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing rifabutin

Company Ingredient NDC Excipient
Marlex Pharmaceuticals Inc rifabutin 10135-738 ALCOHOL
Marlex Pharmaceuticals Inc rifabutin 10135-738 AMMONIA
Marlex Pharmaceuticals Inc rifabutin 10135-738 BUTYL ALCOHOL
Marlex Pharmaceuticals Inc rifabutin 10135-738 CELLULOSE, MICROCRYSTALLINE
Marlex Pharmaceuticals Inc rifabutin 10135-738 FERRIC OXIDE RED
Marlex Pharmaceuticals Inc rifabutin 10135-738 FERROSOFERRIC OXIDE
Marlex Pharmaceuticals Inc rifabutin 10135-738 GELATIN
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for rifabutin

Excipient focus: ALCOHOL

Excipient focus: AMMONIA

Excipient focus: BUTYL ALCOHOL

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSPOVIDONE

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

rifabutin drug variants not containing MICROCRYSTALLINE CELLULOSE 101

Company Ingredient NDC
Pfizer Laboratories Div Pfizer Inc rifabutin 0013-5301
Marlex Pharmaceuticals Inc rifabutin 10135-738
Physicians Total Care Inc rifabutin 54868-2841
Department of State Health Services Pharmacy Branch rifabutin 55695-010
Greenstone LLC rifabutin 59762-1350
REMEDYREPACK INC rifabutin 70518-3731
Novitium Pharma LLC rifabutin 70954-041
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: TITANIUM DIOXIDE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group